Why The Five & One?
Health care doesn’t fail women because we lack information. It fails because systems are slow to change and rarely built around women’s bodies, lives, or timelines.
Each week, we share five signals shaping women’s health — across care, policy, research, and access — plus one thing just for you.
This week
The renaming of PCOS, AI that could shorten the wait for a diagnosis, new evidence that menopause brain fog is real, and why hydration science still treats women as an afterthought.
01. Midlife Is Not a Niche
In a new TIME Q&A, Melinda French Gates argues that midlife women’s health is one of the most overlooked opportunities in health care. For decades, investment has focused on the reproductive years — leaving menopause and the decades after it under-researched and underfunded. Yet women now spend nearly half their lives in the years after menopause.
The Breakdown
Women’s health has long been defined by fertility, pregnancy, and childbirth.
Research, funding, and new products drop off sharply after the reproductive years.
Menopause affects every woman, but clinician training is inconsistent — and symptoms get dismissed as “just aging.”
Midlife is when risks for heart disease, bone loss, dementia, and metabolic disease climb.
The Breakthrough: Major funders and health leaders are starting to treat midlife as a critical health phase, not a footnote. Menopause is being recognized as a window into heart, brain, and bone health; the conversation is shifting from managing symptoms to preventing disease; and growing visibility is normalizing conversations that were once taboo.
Source: TIME
02. From PCOS to PMOS: Why the Name Matters
For decades, Polycystic Ovary Syndrome (PCOS) has been one of the most misunderstood conditions affecting women — it impacts an estimated 6–13% of women of reproductive age worldwide. Now the American Society for Reproductive Medicine and international experts are backing a new name: PMOS (Polyfollicular Metabolic-Ovarian Syndrome) — a name that points to hormones and metabolism, not just the ovaries.
The Breakdown
The name “PCOS” is misleading — many women with the condition don’t have ovarian cysts at all.
Focusing on the ovaries hid its real roots: insulin resistance, inflammation, and higher heart-disease risk.
Symptoms span several specialties (gynecology, endocrinology, dermatology, primary care), so diagnosis often takes years.
The old name made it seem like a fertility problem, when it also affects metabolic health, mental health, and long-term disease risk.
The Breakthrough: The new name reflects what the science now shows: this is a metabolic and hormonal disorder, not simply an ovarian one. A clearer name can shift care from treating symptoms toward whole-body treatment and prevention, and sharpen research, patient education, and collaboration across specialties.
Source: ASRM
03. AI, Earlier Answers, and One of Women’s Health’s Biggest Gaps
Women routinely wait years for answers to complex conditions — ovarian cancer, endometriosis, autoimmune disease, hormonal disorders. Diagnosis drags because symptoms are vague, data is scattered, and most tools are built to catch disease only after it has advanced. A new collaboration between Aspira Women’s Health and Cleveland Clinic aims to use AI to improve accuracy and speed up detection.
The Breakdown
Many women’s health conditions are diagnosed years after symptoms begin.
Symptoms are vague and easy to confuse with other conditions, and diagnosis relies on one test after another.
A woman’s health data is spread across different providers and systems, and women’s health draws less investment in diagnostic innovation than other fields.
Conditions like ovarian cancer are often caught late, when outcomes are worse.
The Breakthrough: AI can spot patterns across large, complex datasets that humans may miss. The Aspira–Cleveland Clinic effort focuses on tools built specifically for women’s health — which could shorten the path to a diagnosis and allow treatment before disease becomes harder to treat.
Source: Cleveland Clinic
04. Brain Fog Isn’t Just in Your Head
For years, women have described memory lapses, trouble concentrating, and mental fuzziness during menopause — often brushed off as stress, aging, or something to simply endure. A new study highlighted by Women’s Health adds to growing evidence that these changes are real, measurable, and tied to the menopause transition itself.
The Breakdown
Menopause-related memory and focus changes are under-recognized and have long been under-researched.
Women often report these changes years before anyone validates them or explains why.
Brain fog gets treated as a quality-of-life nuisance, even though it can affect work, confidence, and relationships.
Many clinicians get little training on menopause and its effects on the brain.
The Breakthrough: New research is helping measure and validate these changes, and scientists are digging into how estrogen affects the brain and memory. The conversation is moving from “it’s all in your head” to “this is happening in your brain” — which should lead to better screening, education, and treatment.
Source: Women’s Health
05. The Missing Science of Women’s Performance
For decades, much of sports science, exercise physiology, and hydration research was done mostly in men, then applied to women. Unsurprisingly, that leaves big gaps in what we know about how women’s bodies handle exercise, heat, recovery, and hydration across different life stages. A new women-focused hydration initiative from the Gatorade Sports Science Institute aims to start closing them.
The Breakdown
Foundational hydration and performance research was done in men — like much of health research.
Hormonal shifts affect fluid balance, heat management, and recovery.
Pregnancy, postpartum, and menopause add changes that are rarely studied.
Women usually get general hydration advice that may not fit sex-specific differences.
The Breakthrough: The initiative treats women as subjects who need dedicated research, not a subgroup added on. Researchers will look at how hydration needs change across a woman’s life — work that could improve performance, recovery, and safety, and eventually shape everything from sports nutrition products to clinical recommendations.
Source: Nutrition Insight
Your+1: You’re invited!
This week we’re opening one of our member-only events to the entire Five & One community.
Tracked vs. Treated: Two CEOs on Women’s Health Devices brings together two leaders building the tools women actually use. Liz Gazda, CEO of Embr Labs, and Colette Courtion, CEO of Joylux, join us to talk about where women’s health devices are headed — from what your body is tracking to what it’s treating — what the data can and can’t do yet, and where the biggest opportunities for women lie.
As always, we’ll leave plenty of room for questions and the kind of candid conversation that rarely happens in public.
Consider this your invitation to pull up a chair.
📅 June 16th, 12:00 PM ET
Register here: Join the Event
Normally reserved for members — open to all Five & One readers this week.
. . .
P.S. We spent this whole issue talking about menopause brain fog and then almost forgot to write the PS. The research checks out. 🧠☕.